Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-26T08:53:40.611Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of nesiritide in critically ill children with biventricular dysfunction suffering from oliguria despite standard heart-failure management

Published online by Cambridge University Press:  23 December 2015

Bibhuti B. Das ,
Joshua Koch ,
Vivian Dimas ,
Kristine Guleserian  and
Alan Nugent Open the ORCID record for Alan Nugent [Opens in a new window]
Bibhuti B. Das*
Affiliation:
Department of Pediatrics, Children’s Medical Center, UT Southwestern Medical Center, Dallas, Texas, United States of America
Joshua Koch
Affiliation:
Department of Pediatrics, Children’s Medical Center, UT Southwestern Medical Center, Dallas, Texas, United States of America
Vivian Dimas
Affiliation:
Department of Pediatrics, Children’s Medical Center, UT Southwestern Medical Center, Dallas, Texas, United States of America
Kristine Guleserian
Affiliation:
Department of Cardiovascular and Thoracic Surgery, Children’s Medical center, UT Southwestern Medical center, Dallas, Texas, United States of America
Alan Nugent
Affiliation:
Department of Pediatrics, Children’s Medical Center, UT Southwestern Medical Center, Dallas, Texas, United States of America
*
Correspondence to: B. B. Das, MD, Associate Professor, Division of Pediatric Cardiology, Children’s Medical Center, UT Southwestern Medical Center, Dallas, TX 75235, United States of America. Tel: +214 456 6333; Fax: +214 456 7758; E-mail: bdas99@hotmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Although nesiritide has been used in adults with left heart failure, the experience in the paediatric population is limited. We reviewed and analysed our experience with continuous nesiritide infusion as adjunct therapy in children with biventricular dysfunction due to diverse aetiologies and suffering from oliguria despite intravenous diuretics and inotropic therapies for heart-failure management.

Keywords

B-type natriuretic peptidenesiritidepaediatric heart failureleft ventricular assist devicetotal artificial heart
Type
Brief Reports
Information
Cardiology in the Young , Volume 26 , Issue 4 , April 2016 , pp. 819 - 823
Check for updates
Copyright
© Cambridge University Press 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Abraham, WT, Cheng, ML, Smoluk, G. Vasodilatation in the Management of Acute CHF (VMAC) Study Group. Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers. Congest Heart Fail 2005; 11: 59–64.CrossRefGoogle Scholar
2. O’Connor, CM, Starling, RC, Hernandez, AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365: 32–43.CrossRefGoogle ScholarPubMed
3. Dontas, ID, Xanthos, T, Dontas, I, Lelovas, P, Papadimitriou, L. Impact of nesiritide on renal function and mortality in patients suffering from heart failure. Cardiovasc Drugs Ther 2009; 23: 221–233.CrossRefGoogle ScholarPubMed
4. Rosenthal, DN, Shaddy, R. ISHLT guidelines for the management of pediatric heart failure. In R Kirk, A Dipchand, D Rosenthal, (eds) ISHLT Monograph Series, Chapter 6. UAB, Birmingham, Alabama, 2014: 119–141.Google Scholar
5. Feingold, B, Law, YM. Nesiritide use in pediatric patients with congestive heart failure. J Heart Lung Transplant 2004; 23: 1455–1459.CrossRefGoogle ScholarPubMed
6. Simsic, JM, Reddy, VS, Kanter, KR, et al. Use of nesiritide (human B-type natriuretic peptide) in infants following cardiac surgery. Pediatr Cardiol 2004; 25: 668–670.CrossRefGoogle ScholarPubMed
7. Marshall, J, Berkenbosch, JW, Russo, P, et al. Preliminary experience with nesiritide in the pediatric population. J Intensive Care Med 2004; 19: 164–170.CrossRefGoogle ScholarPubMed
8. Jefferies, JL, Denfield, SW, Price, JF, et al. A prospective evaluation of nesiritide in the treatment of pediatric heart failure. Pediatr Cardiol 2006; 27: 402–407.CrossRefGoogle ScholarPubMed
9. Mahle, WT, Cuadrado, AR, Kirshbom, PM, Kanter, KR, Simsic, JM. Nesiritide in infants and children with congestive heart failure. Pediatr Crit Care Med 2005; 6: 543–546.CrossRefGoogle ScholarPubMed
10. Kelesidis, I, Mazurek, JA, Saeed, W, et al. Effect of nesiritide in isolated right ventricular failure secondary to pulmonary hypertension. Congest Heart Fail 2012; 18: 18–24.CrossRefGoogle ScholarPubMed
11. Gottlieb, S, Stebbins, A, Voors, AA, et al. Effects of nesiritide and predictors of urine output in acute decompensated heart failure. Results from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure). J Am Coll Cardiol 2013; 62: 1177–1183.CrossRefGoogle ScholarPubMed
12. Costello, JM, Dunbar-Masterson, C, Allan, CK, et al. Impact of empiric nesiritide or milrinone infusion on early postoperative recovery after Fontan surgery. A randomized, double-blind, placebo-controlled trail. Circ Heart Fail 2014; 7: 596–604.CrossRefGoogle ScholarPubMed
13. Delgado, R, Wadia, Y, Kar, B, et al. Role of B-type natriuretic peptide and effect of nesiritide after total cardiac replacement with Abiocor total artificial heart. J Heart Lung Transplant 2005; 24: 1166–1170.CrossRefGoogle ScholarPubMed
14. Schrier, RW, Abraham, WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999; 341: 577–585.CrossRefGoogle ScholarPubMed
15. Farrar, DJ, Compton, PG, Hershon, JJ, et al. Right heart interaction with the mechanically assisted left heart. World J Surg 1985; 9: 89–102.CrossRefGoogle ScholarPubMed
16. Moon, MR, Bolger, AF, DeAnda, A, et al. Septal function during left ventricular unloading. Circulation 1997; 95: 1320–1327.CrossRefGoogle ScholarPubMed
17. Gaies, MG, Gurney, JG, Yen, AH, et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med 2010; 11: 234–238.CrossRefGoogle ScholarPubMed